IL-2-anti-IL-2 Complexes In Immunity To Blood Stage Malaria Infection And Prevention Of Cerebral Immunopathology
Funder
National Health and Medical Research Council
Funding Amount
$586,428.00
Summary
Cerebral malaria is a severe complication of malaria infection, which accounts for a large proportion of malaria-related deaths each year. There is no vaccine against malaria licensed for use in humans. Trial vaccines have been shown to protect poorly against cerebral malaria, and have on occasion, increased the its incidence amongst experimental animals. We aim to develop a safe malaria vaccine that controls malaria parasite numbers in the body, and also prevents cerebral malaria.
Protecting Against Malaria Through Liver-resident Memory T Cells
Funder
National Health and Medical Research Council
Funding Amount
$1,196,853.00
Summary
We have shown that formation of liver-resident memory T cells (Trm), a newly discovered type of immune cells, can be induced by an innovative vaccination strategy called prime and trap for highly efficient protection against malaria in mice. Here, we will enhance prime and trap vaccination efficacy by defining the conditions that maximize liver Trm-mediated protection and will characterize simian and human liver Trm cells, paving the way to create the most efficient human malaria vaccine to date
Identifying T Cell Correlates Of Protective Immunity To Malaria In Childhood
Funder
National Health and Medical Research Council
Funding Amount
$396,026.00
Summary
Malaria claims nearly one million lives each year, mostly children. Although those living in endemic regions can acquire natural immunity, it develops slowly and isn`t completely protective. This project studies the impact of different levels of malaria exposure and age on the development of a protective immune response in children. By understanding the effect of high malaria exposure in the development of immunity it is hoped that new avenues for drug development may be identified.
Immune Surveillance Of The CNS During Malaria Infection
Funder
National Health and Medical Research Council
Funding Amount
$617,857.00
Summary
Infections in the central nervous system (CNS) can have profound neurological complications. Neurological disease caused by cerebral malaria (CM) is a lethal complication in humans. We have established a new model of longitudinal imaging of T cell responses in the brain during experimental CM in mice infected with Plasmodium berghei ANKA. This project will investigate the mechanisms of CNS injury and provide fundamental information about T cell responses in the CNS during infection.
Biochemistry And Cell Biology Of Antigen Presentation And T Cell Activation
Funder
National Health and Medical Research Council
Funding Amount
$763,409.00
Summary
José Villadangos studies the cells and molecules involved in Antigen Presentation. This phenomenon consists of the detection, capture and display of microbe fragments on the surface of Antigen Presenting Cells (APC) for recognition by T cells. This initiates an immune response that culminates in the deployment of cells and molecules armed to fight the infection. His research may lead to development of more effective vaccines and prevention of autoimmunity, allergy and transplant rejection.
Defining The Cellular Interactions For Initiation And Maintenance Of Immunity To Intracellular Pathogens
Funder
National Health and Medical Research Council
Funding Amount
$863,413.00
Summary
This immune system provides our body’s defense against invading organisms like viruses, preventing disease and maintaining health. Immunity involves the interaction of several different cell types that together form arsenals tailored to combat each different infection. Professor Heath will investigate how cells of the immune system orchestrate effective immune responses to viral infections and malaria. He will use this understanding to design novel approaches to vaccination.
Investigating CD4+ T Helper Cell Differentiation During Blood-stage Plasmodium Infection
Funder
National Health and Medical Research Council
Funding Amount
$408,388.00
Summary
Some infections tend to afflict us only once, e.g. chickenpox, because our bodies develop immunity to these microbes relatively easily. In contrast, it takes many infections to develop immunity to the malaria parasite, because our immune systems seem to respond inefficiently to it. My work will improve our understanding of how the immune system is poorly activated during malaria, and may provide new ideas for boosting the immune system in response to malaria or indeed other infections.
Immune Imprinting By Nanoparticles And Vaccines: New Principles And Translation Into The Clinic
Funder
National Health and Medical Research Council
Funding Amount
$631,010.00
Summary
Vaccines require adjuvants to be effective. Despite decades of research there is only one adjuvant approved for broad use in humans. Based on our prior findings I will engage new principles in nanotechnology, and deepen understanding of immune imprinting in various organs of the body including the lung, to develop 2nd generation broadly useful nanoadjuvants able to effectively treat cancer and malaria.